Search
Baxter International Inc
BAXAdd to Watchlist
19.890USD
+0.510+2.63%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
10.27BMarket Cap
LossP/E TTM
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Infusion Therapies and Technologies
4.10B
36.47%
Care and Connectivity Solutions
1.91B
17.00%
Injectables and Anesthesia
1.35B
12.02%
Advanced Surgery
1.20B
10.65%
Front Line Care
1.16B
10.32%
Other
1.52B
13.54%
By RegionUSD
Name
Revenue
Proportion
United States
6.12B
54.45%
International
5.12B
45.55%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Infusion Therapies and Technologies
4.10B
36.47%
Care and Connectivity Solutions
1.91B
17.00%
Injectables and Anesthesia
1.35B
12.02%
Advanced Surgery
1.20B
10.65%
Front Line Care
1.16B
10.32%
Other
1.52B
13.54%
